There was no difference between corticotropin stimulated plasma cortisol or metabolic disorders in patients with the high-sensitivity haplotypes vs. low-sensitivity plus wild-type haplotypes (p > 0.05; Table 6). This evidence concerns the gene POMC and metabolic disease.